Consistent with this, other researchers have found that mice with lactate dehydrogenase A (LDH-A) deficient B16-F10 melanoma have a better response to anti-PD-1 treatment, which is manifested by increased infiltration of NK cells and CD8 + cytotoxic T cells (46). Here, LDHA is linked to melanoma.